Sampre Nutritions Ltd (530617) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 530617 | NSE: | Consumer Food | Small Cap

Sampre Nutritions Share Price

27.70 -1.45 -4.97%
as on 05-Dec'25 11:33

Sampre Nutritions Ltd (530617) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 530617 | NSE: | Consumer Food | Small Cap

DeciZen - make an informed investing decision on Sampre Nutritions

Based on:

Overall Rating
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Sampre Nutritions stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
254.7 Cr.
52-wk low:
5.2
52-wk high:
42.3

Is Sampre Nutritions Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Sampre Nutritions: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Sampre Nutritions Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 11.1%8.8%7.1%8.7%8.5%5.3%6.7%6.6%6.4%-7.1%-
Value Creation
Index
-0.2-0.4-0.5-0.4-0.4-0.6-0.5-0.5-0.5-1.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 45.133.632.728.724.918.223.137.125.225.134
Sales YoY Gr.--25.5%-2.8%-12.2%-13.4%-26.6%26.9%60.4%-32.2%-0.1%-
Adj EPS 0.50.20.10.10.200.20.10.1-0.9-0.7
YoY Gr.--50%-43.5%0%38.5%-77.8%325%-23.5%-15.4%-890.9%-
BVPS (₹) 4.95.15.25.45.65.65.86.97.110.813.7
Adj Net
Profit
0.90.50.20.20.30.10.30.40.3-7.3-6
Cash Flow from Ops. 1.2-11.55.72.6-0.22.40.940.1-
Debt/CF from Ops. 6.6-12.69.43.57.8-119.88.819.14.3196.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -6.3%0.2%2.8%-0.1%
Adj EPS -207.3%-237%-272.3%-890.9%
BVPS9.2%14.3%23.4%52.9%
Share Price 15.3% 43.8% -14.7% 64%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
9.94.72.42.43.20.732.21.4-12.7-5.7
Op. Profit
Mgn %
6.28.99.313.115.718.815.210.916.7-14.9-7.3
Net Profit
Mgn %
21.40.70.91.40.41.40.91.2-29.1-17.9
Debt to
Equity
0.81.31.41.91.921.90.90.90.20.1
Working Cap
Days
7111912816019227724116826828286
Cash Conv.
Cycle
33567773621251309315716527

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Sampre Nutritions Ltd.

Standalone Consolidated
TTM EPS (₹) -0.7 -0.7
TTM Sales (₹ Cr.) 34.2 34.2
BVPS (₹.) 13.7 13.7
Reserves (₹ Cr.) 76 76
P/BV 2.13 2.13
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 5.22 / 42.33
All Time Low / High (₹) 0.26 / 74.09
Market Cap (₹ Cr.) 255
Equity (₹ Cr.) 43.7
Face Value (₹) 5
Industry PE 59.8

Management X-Ray of Sampre Nutritions:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Sampre Nutritions - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Sampre Nutritions

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales45343329251823372525
Operating Expenses 42313025211520332129
Manufacturing Costs1077410810141215
Material Costs302120188471558
Employee Cost 0011111111
Other Costs 2222222335
Operating Profit 333443344-4
Operating Profit Margin (%) 6.1%8.9%9.3%13.0%15.7%18.8%15.1%10.9%16.7%-14.9%
Other Income 0000000000
Interest 1112222222
Depreciation 1111122222
Exceptional Items 0000000000
Profit Before Tax 110000001-7
Tax 0000000000
Profit After Tax 100000000-7
PAT Margin (%) 1.9%1.3%0.7%0.8%1.4%0.4%1.3%0.9%1.2%-29.1%
Adjusted EPS (₹)0.50.20.10.10.20.00.20.10.1-0.9
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 9101010111111192191
Share Capital 55555557721
Reserves 5556666121370
Minority Interest0000000000
Debt7131318192121151615
Long Term Debt4791111121311911
Short Term Debt4647888565
Trade Payables4226554425
Others Liabilities 3123322667
Total Liabilities 242627383738384445117

Fixed Assets

Gross Block22232933373440404243
Accumulated Depreciation13141617191617192123
Net Fixed Assets 991315191822212120
CWIP 4629550455
Investments 00000000071
Inventories2456777786
Trade Receivables6555466779
Cash Equivalents 0000100000
Others Assets 2323222446
Total Assets 242627383738384445117

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 1-1163-02140
PBT 110000001-7
Adjustment 2223233443
Changes in Working Capital -1-4-13-0-3-1-3-04
Tax Paid -0-0-0-0-0-0-0-00-0
Cash Flow From Investing Activity -4-3-2-10-1-1-1-4-4-75
Capex -4-3-2-10-1-1-1-4-4-0
Net Investments 0000000000
Others 00000000-0-75
Cash Flow From Financing Activity 3405-10-23-075
Net Proceeds from Shares 000000010177
Net Proceeds from Borrowing 2333-111-2-11
Interest Paid -1-1-0-1-1-1-2-2-2-2
Dividend Paid 0000000000
Others 22-2310-1-22-2
Net Cash Flow 00-001-1-00-0-0

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)9.534.692.432.273.190.72.812.321.57-13.12
ROCE (%)11.148.797.068.718.455.266.656.576.38-7.13
Asset Turnover Ratio2.231.341.220.880.660.480.610.910.570.31
PAT to CFO Conversion(x)1N/AN/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days3959526163989666103113
Inventory Days16334869951431147010697
Payable Days3152347724247624092215145

Sampre Nutritions Ltd Stock News

Sampre Nutritions Ltd FAQs

The current trading price of Sampre Nutritions on 05-Dec-2025 11:33 is ₹27.70.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Sampre Nutritions stood at ₹254.7.
The latest P/E ratio of Sampre Nutritions as of 04-Dec-2025 is 0.00.
The latest P/B ratio of Sampre Nutritions as of 04-Dec-2025 is 2.13.
The 52-week high of Sampre Nutritions is ₹42.33 and the 52-week low is ₹5.22.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sampre Nutritions is ₹34.21 ( Cr.) .

About Sampre Nutritions Ltd

Sampre Nutritions was incorporated on December 3, 1991 as a Public company.  Lately it was converted into a public limited company in 16 May 1994.  The company is engaged in the manufacture and sale of sugar-boiled candies and toffees.

The multi-locational facilities of the Group are equipped with APV Baker 4 bank Deposited Line, New generation imported Uni plast lines cut & wrap lines, Cooling equipment and Packing machines. Continuous investments in the latest technology for each of the product lines have ensured the highest global standards. Supporting quality and optimum productivity across the integrated network are world-class laboratories and a strong R&D. The R&D also provides a one-stop source for everything from development to delivery of products to exacting international standards.

The company’s registered office is located at Kiran Arcade, 3 Floor, 100 Sarojini Devi Road Secunderabad,Andhra Pradesh-500003 .

Clientele

  • PROCTER & GAMBLE INDIA LTD  
  • WARNER LAMBERT INDIA LTD
  • CADBURY INDIA LIMITED 
  • INDIAN AIRLINES LTD 
  • RANBAXY LABORATORIES LTD 
  • KNOLL PHARMACEUTICALS LTD (BOOTS) 
  • CIPLA LIMITED
  • DABUR INDIA LIMITED
  • AMRUTANJAN LIMITED
  • AUROBINDO PHARMA LIMITED
  • ANCHOR HEALTH & BEAUTY CARE PVT LTD
  • Dr. MOREPEN LABORATORIES LTD
  • HIMALAYA DRUG COMPANY
  • BAIDYANATH AYURVED BHAVAN PVT LTD
  • ELDER PHARMACEUTICALS LTD
  • MICRONUTRIENT, CANADA
  • ITC LIMITED

Awards and Achievements

The quality initiatives have credited the Group with many coveted citations viz., Pinnacle Awards by P&G, USA for Outstanding Quality Assurance Standards for 2 consecutive years, and the Golden Peacock National Quality Award in 1998 for Outstanding Quality Efforts in Small Sector Manufacturing.

The Rajiv Gandhi National Quality Award given by the Govt. of India and an ISO 9002 certification was topped by Sampre becoming the first confectionery Company in South East Asia to receive HACCP certification - the highest quality certification from BVQI –Netherlands for the Food industry.


  •  
  • To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

    © 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

    ×